Stocks and Investing Stocks and Investing
Wed, September 11, 2019
Tue, September 10, 2019

Sumant Kulkarni Upgraded (ACAD) to Strong Buy on, Sep 10th, 2019


Published on 2024-10-26 16:06:21 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Upgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Strong Buy on, Sep 10th, 2019.

Sumant has made no other calls on ACAD in the last 4 months.



There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, 1 agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $28 on, Tuesday, September 3rd, 2019


These are the ratings of the 3 analyists that currently disagree with Sumant


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $60 on, Monday, September 9th, 2019
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $40 on, Tuesday, August 27th, 2019
  • Danielle Brill of "Raymond James" Reiterated at Strong Buy with Increased Target to $43 on, Friday, May 31st, 2019

Contributing Sources